First-line immunotherapy versus targeted therapy in patients with BRAF-mutant advanced melanoma: a real-world analysis
Author:
Affiliation:
1. Weill Cornell Medical Center, New York, NY 10021, USA
2. Bristol Myers Squibb, Princeton, NJ 08540, USA
Abstract
Funder
Bristol Myers Squibb
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon-2020-0643
Reference22 articles.
1. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Cancer stat facts: melanoma of the skin (2019). https://seer.cancer.gov/statfacts/html/melan.html
2. Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
3. Melanoma and Immune Checkpoint Inhibitors
4. The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
5. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Features, management, and outcomes of pediatric scalp melanomas;Pediatric Dermatology;2023-12-21
2. Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade;2023-12-21
3. Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation;International Journal of Molecular Sciences;2023-09-07
4. Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study);Cancer Medicine;2023-08-16
5. Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?;Cancer and Metastasis Reviews;2023-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3